Monitoring of patients with cancer during treatment.
Study description
An interventional, one-arm study to assess remote monitoring of patients using the Cabozantinib/Nivolumab combination in advanced, metastatic kidney cancer.
Key results
Under development
Recruitment started in October 2025. Study ongoing.
Publication
https://www.asco.org/abstracts-presentations/256910
